Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Radial spoke head protein 9 homolog (RSPH9) is a structural protein component of the radial spoke head complex found in motile cilia and flagella. It helps form the core scaffold of the radial spoke head, a mechanochemical signaling structure critical for the proper motility and waveform of cilia. The protein is essential for the assembly and maintenance of the radial spoke apparatus and for the stability of the central microtubule pair in cilia. Germline mutations in RSPH9 disrupt cilia and sperm motility, resulting in primary ciliary dyskinesia, a recessive genetic disorder characterized by impaired mucociliary clearance, chronic respiratory infections, and, in some cases, infertility and sensory defects. There are no known drugs directly targeting RSPH9, and its principal biological roles are structural and essential for organelle function rather than classical pharmacology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Radial spoke head protein 9 homolog (RSPH9).